m 6 A‐Dependent ITIH1 Regulated by TGF‐β Acts as a Target for Hepatocellular Carcinoma Progression
Advanced Science · 2024
DOI: 10.1002/advs.202401013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhibin Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Transforming Growth Factor beta, Disease Progression. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Graduates' Innovation Fund, Huazhong University of Science and Technology.
Abstract (Originalsprache)
Both the transforming growth factor beta (TGF‐β) signaling pathway and N6‐methyladenosine (m 6 A) modification for mRNA play an important role in hepatocellular carcinoma (HCC) progression. However, the relationship between TGF‐β and m 6 A in hepatocellular carcinoma (HCC) remains unclear. Here, it is found that TGF‐β can promote the liquid phase separation of METTL3, which further leads to the reduction of mRNA stability of ITIH1. As a secreted protein, ITIH1 can act as a ligand of integrin α5β1 to antagonize fibronectin, induce the inhibition of focal adhesion kinase signaling pathway, and inhibit the progression of HCC. In the preclinical model (mouse model, patient‐derived organoid, patient‐derived xenografts), purified recombinant ITIH1 (r‐ITIH1) protein can be targeted for HCC. More importantly, r‐ITIH1 can play a synergistic role in targeting HCC with TGF‐β inhibitor. The downstream ITIH1 regulatory mechanism of TGF‐β and m 6 A modification is revealed, and ITIH1 can be translational as a potential target for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
- Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, Hubei, 430030, China.
- Key Laboratory of Organ Transplantation, Ministry of Education and Ministry of Health, Wuhan, Hubei, 430030, China.
ORCID-Profile: Zhanguo Zhang
Förderung
- National Natural Science Foundation of China
- Graduates' Innovation Fund
- Huazhong University of Science and Technology
Zitieren
APA
Liao, Z., Zhang, H., Liu, F., Wang, W., Liu, Y., Su, C., Zhu, H., Chen, X., Zhang, B., & Zhang, Z. (2024). m 6 A‐Dependent ITIH1 Regulated by TGF‐β Acts as a Target for Hepatocellular Carcinoma Progression. Advanced Science. https://doi.org/10.1002/advs.202401013
Vancouver
Liao Z, Zhang H, Liu F, Wang W, Liu Y, Su C, et al. m 6 A‐Dependent ITIH1 Regulated by TGF‐β Acts as a Target for Hepatocellular Carcinoma Progression. Advanced Science. 2024. doi:10.1002/advs.202401013
BibTeX
@article{Liao2024,
author = {Liao, Zhibin and Zhang, Hongwei and Liu, Furong and Wang, Weijian and Liu, Yachong and Su, Chen and Zhu, He and Chen, Xiaoping and Zhang, Bixiang and Zhang, Zhanguo},
title = {m 6 A‐Dependent ITIH1 Regulated by TGF‐β Acts as a Target for Hepatocellular Carcinoma Progression},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202401013}
}
EUVIMED